THE SOLUTION

THE PROBLEM 
Being in the hospital for any kind of procedure is stressful enough, for patients as well as for the medical staff. Bacteria and biofilm are dangerous elements that add to an already extremely hazardous environment. Unfortunately, in the global healthcare systems, infections due to bacteria are a continuous and unsolved problem. Antibiotics bacterial resistance is a growing problem around the world, responsible for two million infections cases each year that lead to approximately 73,000 deaths in the US.
THE SOLUTION
NanoSono Ltd. (NSC Ltd.) is in the key position to offer a cost-effective solution to a soon-to-be standardized market. In the near future, medical devices, fabrics that are potentially infection causes will require to gain anti-bacterial capabilities to be allowed within patient environments. The most effective way to protect the patients’ and the staffs’ environment is by avoiding the infection in the first place, preferably by eradicating the bacteria from the devices and the equipment that comes in contact with the patients and the hospital stuff. In addition, we make sure the patients’ environment, such as operating rooms, is as sterile as possible, we are also focused on lowering the risk of infection by making “carrier” materials within the patients’ direct environment such as robes, linens etc. anti-bacterial.

Destroys bacteria
within minutes

efficacy on top 5 antibiotic
resistant superbugs bacteria

Long term antibacterial
protection

We have spent years of research and development for an effective solution to this growing problem. We have developed an arsenal of antibacterial coating that can be easily coated on many medical device, fabrics, filters as well as a myriad of consumer products using a simple process that can virtually eradicate the most common types of bacteria endangering people. By implementing our patented nanotechnology into widely used medical devices and products, we play a powerful role in reducing and eliminating the infections, as well as drastically impact the future development of anti-bacterial medicines.